Edit |   |
---|---|
Antigenic Specificity | CD20, Human (Ofatumumab biosimilar) |
Clone | Ofatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD20 Recombinant Antibody (Ofatumumab). Ofatumumab, sold under the brand name Arzerra among others, is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and for the treatment of multiple sclerosis. |
Immunogen | n/a |
Other Names | Anti-CD20 Recombinant Antibody, Research Grade Ofatumumab, Anti-Human CD20 Recombinant Antibody(Ofatumumab), HuMax-CD20, Antibody Drug Analogues, Monoclonal Antibody, YR1129, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 679818-59-8 |
Catalog # | YR1129 |
Price | please inquire |
Order / More Info | CD20, Human (Ofatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |